| Table 1. Cycle characteristics and laboratory outcomes according to stimulation protocol and overall oocyte donor cohort (n=131) |
| Variable |
Protocol 2 Empirical monotherapy(n=13) |
Protocol 3Mixed HMG(n=99) |
Protocol 5Others(n=19) |
Oocyte donoroverall(n=131) |
| Age (years) |
27.5±5.8 |
29.6±3.9 |
28.7±4.7 |
29.3±4.3 |
| Weight (kg) |
66.6±10.7 |
63.9±10.2 |
64.9±8.7 |
64.3±10.0 |
| Partner age (years) |
33.5±8.1 |
34.2±5.9 |
36.7±6.7 |
- |
| AMH (ng/mL) |
4.5±2.0 (n=13) |
4.6±2.5 (n=42) |
5.7±1.7 (n=10) |
4.8±2.4 |
| AFC |
22.2±7.9 |
23.1±7.3 |
26.4±9.9 |
23.4±7.7 |
| Duration of stimulation (days) |
10.1±0.5 |
9.8±1.1 |
9.7±0.8 |
9.8±1.0 |
| Oocytes retrieved (n) |
26.2±9.2 |
26.6±10.7 |
28.5±14.8 |
26.8±11.2 |
| MII oocytes (n) |
20.5±6.7 |
18.9±8.7 |
19.1±13.3 |
19.1±9.3 |
| Top-quality blastocysts (n) |
4.3±2.4 |
3.0±2.2 |
2.4±1.8 |
3.1±2.2 |
| FORT (%) |
49.5±30.7 |
57.1±28.9 |
58.0±30.5 |
56.3±29 |
| Maturity rate (%) |
81.1±14.3 |
71.5±19.1 |
65.0±17.4 |
71.5±18.7 |
| Fertilization rate (%) |
80.3±14.9 |
81.8±13.9 |
81.2±14.5 |
81.5±14.1 |
| Cleavage rate (%) |
90.8±23.5 |
93.1±20.1 |
86.2±28.8 |
91.7±21.8 |
| Blastulation rate (%) |
65.3±19.6 |
61.1±23.4 |
52.4±39.1 |
60.3±25.7 |